127 related articles for article (PubMed ID: 12570342)
1. Anticarcinogenicity of monocyclic phenolic compounds.
Williams GM; Iatropoulos MJ; Jeffrey AM
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S101-7. PubMed ID: 12570342
[TBL] [Abstract][Full Text] [Related]
2. Effect of butylated hydroxytoluene and butylated hydroxyanisole on the mutagenicity of 3,2'-dimethyl-4-aminobiphenyl.
Reddy BS; Sharma C; Mathews L
Nutr Cancer; 1983; 5(3-4):153-8. PubMed ID: 6366755
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of acetaminophen against colon cancer initiation effects of 3,2'-dimethyl-4-aminobiphenyl in rats.
Williams GM; Iatropoulos MJ; Jeffrey AM; Shirai T
Eur J Cancer Prev; 2002 Feb; 11(1):39-48. PubMed ID: 11917207
[TBL] [Abstract][Full Text] [Related]
4. Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.
Chang SH; Chen GW; Yeh CC; Hung CF; Lin SS; Chung JG
Anticancer Res; 2001; 21(2A):1087-93. PubMed ID: 11396144
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
Guarisco JA; Hall JO; Coulombe RA
Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of binding of 2-acetylaminofluorene to DNA by butylated hydroxytoluene and butylated hydroxyanisole in vitro.
Richer N; Marion M; Denizeau F
Cancer Lett; 1989 Oct; 47(3):211-6. PubMed ID: 2635643
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.
Williams GM; Iatropoulos MJ
Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745
[TBL] [Abstract][Full Text] [Related]
8. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
Williams GM; Tanaka T; Maeura Y
Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis.
Masui T; Tsuda H; Inoue K; Ogiso T; Ito N
Jpn J Cancer Res; 1986 Mar; 77(3):231-7. PubMed ID: 3084413
[TBL] [Abstract][Full Text] [Related]
10. Effects of the butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the arylamines N-acetyltransferase activity in rat white blood cells.
Lu HF; Wu HC; Chang WC; Chung JG
Cytobios; 1999; 100(395):159-69. PubMed ID: 10701096
[TBL] [Abstract][Full Text] [Related]
11. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes.
Levine WG
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):113-20. PubMed ID: 6438741
[TBL] [Abstract][Full Text] [Related]
12. Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants.
Kashfi K; Yang EK; Chowdhury JR; Chowdhury NR; Dannenberg AJ
Cancer Res; 1994 Nov; 54(22):5856-9. PubMed ID: 7954414
[TBL] [Abstract][Full Text] [Related]
13. Modulation of azaserine-induced pancreatic foci by phenolic antioxidants in rats.
Roebuck BD; MacMillan DL; Bush DM; Kensler TW
J Natl Cancer Inst; 1984 Jun; 72(6):1405-10. PubMed ID: 6610071
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of cancer: phenolic antioxidants (BHT, BHA).
Hocman G
Int J Biochem; 1988; 20(7):639-51. PubMed ID: 3053283
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT).
Saito M; Sakagami H; Fujisawa S
Anticancer Res; 2003; 23(6C):4693-701. PubMed ID: 14981915
[TBL] [Abstract][Full Text] [Related]
16. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation.
Shirai T; Fukushima S; Kawabe M; Shibata M; Iwasaki S; Tada M; Ito N
Carcinogenesis; 1991 Jul; 12(7):1335-9. PubMed ID: 1906380
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of chemical-induced experimental cancer by synthetic phenolic antioxidants.
Williams GM
Toxicol Ind Health; 1993; 9(1-2):303-8. PubMed ID: 8418519
[No Abstract] [Full Text] [Related]
19. [Protection against synergistic hepatocarcinogenesis of hepatitis B virus expression and aflatoxin B1 by antioxidant 2(3)-tert-4 -hydroxyanisole (BHA) in HBV large envelope transgenic mice].
Wang J; Wang L; Lin S
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):94-7. PubMed ID: 11864462
[TBL] [Abstract][Full Text] [Related]
20. Phenolic antioxidants: Health Protection Branch studies on butylated hydroxyanisole.
Iverson F
Cancer Lett; 1995 Jun; 93(1):49-54. PubMed ID: 7600543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
